Will the use of low-molecular-weight heparin (enoxaparin) in patients with acute coronary syndrome save costs in Canada?
- DOI
- 10.1067/mhj.2000.103552
- Published
- 2000-03
- Container
- American Heart Journal
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1067/mhj.2000.103552,
title = {Will the use of low-molecular-weight heparin (enoxaparin) in patients with acute coronary syndrome save costs in Canada?},
author = {Bernie J. O[rsquo ]Brien and Andrew J. Willan and Gordon J. Blackhouse and Ron J. Goeree and Marc J. Cohen and Shaun J. Goodman},
year = {2000},
journal = {American Heart Journal},
doi = {10.1067/mhj.2000.103552},
url = {https://doi.org/10.1067/mhj.2000.103552}
}RIS
TY - JOUR TI - Will the use of low-molecular-weight heparin (enoxaparin) in patients with acute coronary syndrome save costs in Canada? AU - Bernie J. O[rsquo ]Brien AU - Andrew J. Willan AU - Gordon J. Blackhouse AU - Ron J. Goeree AU - Marc J. Cohen AU - Shaun J. Goodman PY - 2000 JO - American Heart Journal DO - 10.1067/mhj.2000.103552 UR - https://doi.org/10.1067/mhj.2000.103552 ER -
APA
]Brien, B. J. O., Willan, A. J., Blackhouse, G. J., Goeree, R. J., Cohen, M. J., & Goodman, S. J. (2000). Will the use of low-molecular-weight heparin (enoxaparin) in patients with acute coronary syndrome save costs in Canada?. American Heart Journal. https://doi.org/10.1067/mhj.2000.103552
Source records
- crossref · retrieved 2026-09-25T11:24:16.286Z